Standardized commercial parenteral nutrition (PN) formulations have advantages and disadvantages as compared with PN formulations compounded using an automated compounding device. These advantages and disadvantages are discussed along with the supporting available research. (JPEN J Parenter Enteral Nutr. 2012;36:40S-41S)
KochevarMGuenterPHolcombeBMaloneAMirtalloJ; A.S.P.E.N. Board of Directors and Task Force on Parenteral Nutrition Standardization. A.S.P.E.N. statement on parenteral nutrition standardization. JPEN J Parenteral Enteral Nutr. 2007;31:444-448.
LustigA. Medication error prevention by pharmacist: an Israeli solution. Pharm World Sci. 2000;22:21-25.
4.
FlynnEAPearsonREBarkerKN. Observational study of accuracy in compounding i.v. admixtures at five hospitals. Am J Health Syst Pharm. 1997;54:904-912.
5.
MirtalloJCanadaTJohnsonD; Task Force for the Revision of Safe Practices for Parenteral Nutrition. Safe practices for parenteral nutrition. JPEN J Parenteral Enteral Nutr. 2004;28:S39-S70.
6.
TurpinRSCanadaTLiuRXMercaldiCJPontes-ArrudaAWishchmeyerP. Nutrition therapy cost analysis in the US: pre-mixed multi-chamber bag vs compounded parenteral nutrition. Appl Health Econ Health Policy. 2011;9:281-292.
7.
MillerSJ. Commercial premixed parenteral nutrition: is it right for your institution?Nutr Clin Pract. 2009;24:459-469.
